LDLR and fatty liver disease: HCD feeding stimulated lipid accumulation and hepatic steatosis in Ldlr-/- mice but tsRNA-Glu-CTC ASO treatment ameliorated diet-induced hepatic steatosis in those mice (Fig. 7f).